141 related articles for article (PubMed ID: 33636694)
1. SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.
van den Boorn HG; Abu-Hanna A; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Klarenbeek BR; Slingerland M; Beerepoot LV; Rozema T; Sprangers MAG; Verhoeven RHA; van Oijen MGH; Zwinderman KH; van Laarhoven HWM
J Natl Compr Canc Netw; 2021 Apr; 19(4):403-410. PubMed ID: 33636694
[TBL] [Abstract][Full Text] [Related]
2. SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.
van den Boorn HG; Abu-Hanna A; Ter Veer E; van Kleef JJ; Lordick F; Stahl M; Ajani JA; Guimbaud R; Park SH; Dutton SJ; Bang YJ; Boku N; Mohammad NH; Sprangers MAG; Verhoeven RHA; Zwinderman AH; van Oijen MGH; van Laarhoven HWM
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764578
[TBL] [Abstract][Full Text] [Related]
3. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
4. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
Kuijper SC; Pape M; Haj Mohammad N; van Voorthuizen T; Verhoeven RHA; van Laarhoven HWM
Int J Cancer; 2023 Mar; 152(6):1202-1209. PubMed ID: 36451334
[TBL] [Abstract][Full Text] [Related]
5. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
7. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
8. European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry.
Brenkman HJF; Cho M; Ruurda JP; Song K; Son T; Kim HI; Noh SH; van Hillegersberg R; Hyung WJ
Eur J Surg Oncol; 2019 Jun; 45(6):983-988. PubMed ID: 30654921
[TBL] [Abstract][Full Text] [Related]
9. Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.
van den Boorn HG; Engelhardt EG; van Kleef J; Sprangers MAG; van Oijen MGH; Abu-Hanna A; Zwinderman AH; Coupé VMH; van Laarhoven HWM
PLoS One; 2018; 13(2):e0192310. PubMed ID: 29420636
[TBL] [Abstract][Full Text] [Related]
10. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
11. Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer.
Kuijper SC; Besseling J; Klausch T; Slingerland M; van der Zijden CJ; Kouwenhoven EA; Beerepoot LV; Mohammad NH; Klarenbeek BR; Verhoeven RHA; van Laarhoven HWM
J Clin Epidemiol; 2023 Dec; 164():65-75. PubMed ID: 37871837
[TBL] [Abstract][Full Text] [Related]
12. Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review.
Gupta V; Coburn N; Kidane B; Hess KR; Compton C; Ringash J; Darling G; Mahar AL
J Thorac Cardiovasc Surg; 2018 Aug; 156(2):847-856. PubMed ID: 30011772
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
14. Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term Prognosis.
Markar SR; Mackenzie H; Jemal S; Faiz O; Cunningham D; Hanna GB
Ann Surg; 2018 Apr; 267(4):711-715. PubMed ID: 28323674
[TBL] [Abstract][Full Text] [Related]
15. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
[TBL] [Abstract][Full Text] [Related]
16. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
[TBL] [Abstract][Full Text] [Related]
17. Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based study.
Kuijper SC; Pape M; Vissers PAJ; Jeene PM; Kouwenhoven EA; Haj Mohammad N; Ruurda JP; Sosef MN; Verhoeven RHA; van Laarhoven HWM
Int J Cancer; 2023 Jul; 153(1):33-43. PubMed ID: 36855965
[TBL] [Abstract][Full Text] [Related]
18. A novel prognosis prediction model after completion gastrectomy for remnant gastric cancer: Development and validation using international multicenter databases.
Lu J; Zheng ZF; Zhou JF; Xu BB; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Truty MJ; He QL; Huang CM
Surgery; 2019 Sep; 166(3):314-321. PubMed ID: 31221436
[TBL] [Abstract][Full Text] [Related]
19. Trends in treatment and overall survival among patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
[TBL] [Abstract][Full Text] [Related]
20. Informing Patients With Esophagogastric Cancer About Treatment Outcomes by Using a Web-Based Tool and Training: Development and Evaluation Study.
van de Water LF; van den Boorn HG; Hoxha F; Henselmans I; Calff MM; Sprangers MAG; Abu-Hanna A; Smets EMA; van Laarhoven HWM
J Med Internet Res; 2021 Aug; 23(8):e27824. PubMed ID: 34448703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
